Yasine Malki
Sar, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Sequencing of Pleural Fluid and Plasma for Tuberculous Pleuritis.
Journal: NEJM evidence
Published: March 24, 2026
Clinical Variables and Cell-Free DNA Fragmentomics: Biological and Clinical Insights.
Journal: Clinical chemistry
Published: November 11, 2025
Achieving control of nasopharyngeal carcinoma: the role of Epstein-Barr virus-based screening and vaccines.
Journal: Nature reviews. Clinical oncology
Published: September 15, 2025
The comings and goings of cell-free DNA: Biological and clinical implications.
Journal: Med (New York, N.Y.)
Published: July 28, 2025
Long-term oral glucocerebrosidase activator reduces soluble α-synuclein oligomer accumulation in Parkinsonian LRRK2 mutant mouse brain.
Journal: NPJ Parkinson's disease
Published: July 22, 2025
Cell-Free Nucleic Acids for Early Diagnosis of Acute Ischemic Stroke: A Systematic Review and Meta-Analysis.
Journal: International journal of molecular sciences
Published: January 16, 2025
Loss of mitochondrial Ca2+ response and CaMKII/ERK activation by LRRK2R1441G mutation correlate with impaired depolarization-induced mitophagy.
Journal: Cell communication and signaling : CCS
Published: July 22, 2024
Analysis of a cell-free DNA-based cancer screening cohort links fragmentomic profiles, nuclease levels, and plasma DNA concentrations.
Journal: Genome research
Published: June 05, 2024
In vivo overexpression of synaptogyrin-3 promotes striatal synaptic dopamine uptake in LRRK2R1441G mutant mouse model of Parkinson's disease.
Journal: Brain and behavior
Published: August 17, 2022
Transcriptional Regulation of the Synaptic Vesicle Protein Synaptogyrin-3 (SYNGR3) Gene: The Effects of NURR1 on Its Expression.
Journal: International journal of molecular sciences
Published: March 07, 2022
Long-term inhibition of mutant LRRK2 hyper-kinase activity reduced mouse brain α-synuclein oligomers without adverse effects.
Journal: NPJ Parkinson's disease
Published: February 24, 2022
Last Updated: 09/26/2026